Investor Stock List
Ranked #804 of 8,699 institutional investors

Paradigm Biocapital Advisors LP

New York, NY

$5.07B
US stock portfolio at live prices · today −$52.3M (−1.02%)
Live prices, last trade 11:28 AM ET
Value at quarter end (Q3 2026)
$5.03B
Change from Q2 2026
−$311.6M (−5.83%)
Positions
29 · 7 new, 4 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$3.8M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
RVMD 20.1%GMAB 14.2%EWTX 8.58%SYRE 8.38%INSM 7.74%
StockSharesValue, live% of portfoliovs Q2 2026
RVMD Revolution Medicines, Inc.6,219,323$1.02B20.1%Reduced −2%
GMAB Genmab A/S14,136,472$721M14.2%Added +8%
EWTX Edgewise Therapeutics, Inc.10,778,665$435M8.58%Added +6%
SYRE Spyre Therapeutics, Inc.4,457,450$425M8.38%Added +16%
INSM Insmed Incorporated2,695,977$393M7.74%Added +103%
VRDN Viridian Therapeutics, Inc.8,257,672$254M5.01%Added +23%
ORKA Oruka Therapeutics, Inc.2,493,507$234M4.60%Added +16%
MBX MBX Biosciences, Inc.3,772,885$194M3.83%Added +50%
BBIO BridgeBio Pharma, Inc.2,347,850$181M3.57%New
TARS Tarsus Pharmaceuticals, Inc.2,301,375$172M3.40%Reduced −17%
TNGX Tango Therapeutics, Inc.6,961,546$156M3.08%Added +10%
BLTE Belite Bio, Inc1,142,123$149M2.94%Reduced −7%
PCVX Vaxcyte, Inc.2,142,852$122M2.41%Added +1%
ERAS Erasca, Inc.7,998,257$112M2.22%Reduced −16%
JBIO Jade Biosciences, Inc.6,053,268$92.9M1.83%Added +112%
TYRA Tyra Biosciences, Inc.3,510,360$70.5M1.39%Added +92%
OLMA Olema Oncology, Inc.8,720,576$62.2M1.23%Added +1%
OBX Obsidian Therapeutics, Inc.4,155,214$49.6M0.98%New
MANE Veradermics Inc310,060$37.6M0.74%New
ASMB Assembly Biosciences, Inc.1,553,748$34.5M0.68%Unchanged
QUIT Achieve Life Sciences, Inc.4,951,856$28.3M0.56%Unchanged
COAG Hemab Therapeutics Holdings, Inc.629,347$25.0M0.49%New
KRSA Korsana Biosciences, Inc.613,914$22.9M0.45%New
GPCR Structure Therapeutics Inc.1,299,199$21.5M0.42%New
VOR Vor Biopharma Inc.889,575$17.6M0.35%Reduced −49%
EDIT Editas Medicine, Inc.7,575,140$13.1M0.26%Added +36%
ORIC ORIC Pharmaceuticals, Inc.1,505,769$11.4M0.23%New
KARD Kardigan, Inc.900,000$11.0M0.22%Unchanged
IVA Inventiva S.A.808,176$2.6M<0.1%Reduced −80%

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
ALNY Alnylam Pharmaceuticals, Inc.480,000$72.0M
LXEO Lexeo Therapeutics, Inc.4,175,382$13.2M
MPLT MapLight Therapeutics, Inc.685,852$4.3M
EYPT EyePoint, Inc.2,890,397$746K